KRISTEN LUZZI: Open Payments
NPI 1235487737 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,683 in 155 payments from 23 companies in 2025. Trend: 2023 $1,466 · 2024 $2,435 · 2025 $2,683
Food & beverage: $2,484Education: $199
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 21 | $426 |
| Janssen Biotech, Inc. | 14 | $385 |
| MAYNE PHARMA COMMERCIAL LLC | 15 | $244 |
| ABBVIE INC. | 18 | $242 |
| Incyte Corporation | 14 | $208 |
| Amgen Inc. | 12 | $195 |
| UCB, Inc. | 10 | $165 |
| Organon LLC | 9 | $92 |
| Lilly USA, LLC | 5 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $74 |
Products named: TREMFYA, ANZUPGO, ADBRY, OPZELURA, Otezla, Bimzelx, SKYRIZI, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
